Global "Rheumatoid Arthritis Industry" 2016 Market Overview, Trends, Research, survey, Growth, Analysis
Description-
Executive
Summary
Rheumatoid
arthritis
(RA) is a chronic inflammatory disorder that principally attacks
synovial joints. It is one of the most common autoimmune diseases
affecting people of all ages and races. RA affects the lining of
joints, causing a painful swelling that can eventually result in bone
erosion and joint deformity. It also leads to stiffness, and redness
in the joints. The main factor causing rheumatoid arthritis remains
unknown. However, according to studies around the world some of the
genetic and environmental factors are found to be more probable
causers.
Treatment
of Rheumatoid Arthritis involves frequent drugs administration as RA
is a progressive and incurable disease. Drugs used for treatment of
RA are classified as first line agents- consisting of non steroidal
anti-inflammatory drugs (NSAIDs) and steroids such as glucocorticoids
and second line agents- consisting of disease modifying
anti-rheumatic drugs such as chloroquine, gold salts, penicillamine,
cyclosporine, and several biological agents like TNF-
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-rheumatoid-arthritis-market-trends-and-opportunities-2013-2018-report.html
Scope
of the report
The
report titled Global Rheumatoid Arthritis Market: Trends and
Opportunities (2013-2018) provides an in-depth analysis of global
rheumatoid arthritis market with special focus on biologics drugs. It
also accesses the key opportunities and underlying trends in the
market and outlines the factors that are and will be driving the
growth of the industry in the forecasted period (2013-18). Further,
key drug manufacturers of the global rheumatoid arthritis market like
Abbvie Inc. (Humira), Amgen Inc. (Enbrel), Johnson & Johnson
(Remicade), Roche Holdings AG (Actemra) are profiled in the report.
Company
Coverage
- Abbvie Inc.
- Amgen Inc.
- Johnson & Johnson
- Roche Holdings AG
Table
of Content
1.
Executive Summary
2.
Rheumatoid Arthritis: An Introduction
2.1
Rheumatoid Arthritis: Causes
2.2
Rheumatoid Arthritis: Symptoms & Diagnosis
2.2.1
Rheumatoid Arthritis: Symptoms
2.2.2
Rheumatoid Arthritis: Diagnosis
3.
Rheumatoid Arthritis Treatment
3.1
Clinical Evolution of Rheumatoid Arthritis Treatment
3.2
Rheumatoid Arthritis: Drugs Treatment
3.2.1
First line agents
3.2.2
Second line agents
4.
Global Rheumatoid Arthritis Market Analysis
4.1
Global Rheumatoid Arthritis Treatment Market: Size & Growth
(Actual & Forecast)
4.2
Global Rheumatoid Arthritis Treatment Market Analysis
4.2.1
Global Biologics Drugs Market Size (Actual & Forecast)
4.2.2
Global Rheumatoid Arthritis Biologics Drugs Market Share (Actual &
Forecast)
4.2.3
Global TNF-α target Antibody Market Size (Actual & Forecast)
5.
Global Rheumatoid Arthritis Drug Market Analysis
5.1
Global TNF-α target Drugs Market
5.1.1
Global TNF-α target Market Size by Drugs (Actual & Forecast)
5.1.2
TNF-α target Market Share by Drugs (Actual & Forecast)
5.2
Rheumatoid Arthritis Drugs Market: Regional Analysis
5.2.1
Rheumatoid Arthritis Drugs Market Size in the U.S. (2012)
5.2.2
TNFα Blockers Drugs Market Size in the U.S. (2012)
5.2.3
Rheumatoid Arthritis Drugs Market Size in Korea
6.
Global Rheumatoid Arthritis Market: Growth Drivers & Challenges
6.1
Growth Drivers
6.1.1
Increase in Incidence of Patients with Rheumatoid Arthritis
6.1.2
Global Aging Population
6.1.3
Global Healthcare Expenditure
6.2
Challenges
6.2.1
Pricing pressure
6.2.2
Patent Expiries
6.2.3
High Cost of Treatment
6.2.4
High R&D Costs
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment